Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
17 Jul 2024
// BUSINESSWIRE
23 Jan 2023
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2023-01-23/cytoreason-licenses-ibd-disease-model-to-sanofi-in-expanded-alliance/?widget=listSection
21 Sep 2022
// Andrea Park FIERCEBIOTECH
https://www.fiercebiotech.com/medtech/cytoreason-pfizer-ink-110m-five-year-extension-ai-powered-drug-development-deal
20 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/20/2519131/0/en/CytoReason-Announces-Expanded-Collaboration-Deal-with-Pfizer-to-Deliver-AI-for-Drug-Discovery-and-Development.html
20 Sep 2022
// CONTRACTPHARMA
https://www.contractpharma.com/contents/view_breaking-news/2022-09-20/cytoreason-extends-multi-year-partnership-with-pfizer/
13 Apr 2022
// BIOSPECTRUMASIA
https://www.biospectrumasia.com/news/26/20077/cytoreason-expands-reach-in-asia-leveraging-ml-in-drug-development-for-korean-drugmakers-.html
ABOUT THIS PAGE